697 Heart failure patient improvements in clinical status, hospitalisation and costing by multidisciplinary team management programme

2006 ◽  
Vol 5 (1) ◽  
pp. 159-159
Author(s):  
M PIEPOLI ◽  
G VILLANI ◽  
D ASCHIERI ◽  
M PISATI ◽  
E ICONOMOU ◽  
...  
2006 ◽  
Vol 111 (3) ◽  
pp. 377-385 ◽  
Author(s):  
M.F. Piepoli ◽  
G.Q. Villani ◽  
D. Aschieri ◽  
S. Bennati ◽  
F. Groppi ◽  
...  

2019 ◽  
Vol 25 (8) ◽  
pp. S99
Author(s):  
Khalid A.S. Abdalla ◽  
Hussam Ghalib ◽  
Terrence Lee-St John ◽  
Richard Ferrer ◽  
Ziad G. Sadik ◽  
...  

2017 ◽  
Vol 11 (2) ◽  
Author(s):  
Andrea Pizzini ◽  
Marco Badinella Martini

Heart failure is one of the most common and intensely studied diseases in the world. Nevertheless, it is considered a difficult condition to diagnose and manage.This case report, starting from the description of a brief clinical case, aims to directly and concisely explain the most important steps, from laboratory to bedside, in the diagnosis and management of heart failure disease. Physicians can rely on some laboratory tests (e.g., natriuretic peptides) and instrumental exams to diagnose and manage the patients in everyday medical practice. Finally, this article highlights that a multidisciplinary team management can improve the clinical status and the quality of life, thus preventing hospital admission and reducing mortality in patients with heart failure.


Medic ro ◽  
2020 ◽  
Vol 6 (1) ◽  
pp. 8-13
Author(s):  
Roxana Marcela Sânpălean ◽  
Dorina Nastasia Petra

Heart failure (HF) is a burden for the healthcare system. The incidence will increase significantly due to the aging of po­pu­la­tion, which is associated with multiple comorbidities. Ane­mia and iron deficiency are common in patients with HF, their etiology being often multifactorial. The screening for anemia and iron deficiency is recommended as soon as pos­si­ble. There are often no targeted investigations, therefore a significant proportion of cases are underdiagnosed. The ma­nagement of patients may focus on identifying and correcting the cause. Anemia can occur due to nutritional deficiencies, infla­m­mation, renal failure, bone marrow dysfunction, neuro­hor­mo­nal activity, treatment and hemodilution. The appropriate the­ra­py for the patients with anemia and HF will contribute to the improvement of life quality. The only recommended iron product is ferric carboxymalose administered by in­tra­venous infusion. Under the appropriate treatment, the pa­tients showed an increase in effort tolerance, with an im­prove­ment in symptomatology and a lower number of hos­pi­ta­li­za­tion days. The management of these cases is handled by a multidisciplinary team consisting of a general prac­ti­tio­ner, a cardiologist and other specialists if the patient has other comorbidities. The role of the general practitioner is essential, as he can perform proper screening, prevention and management, developed by a multidisciplinary team, in order to reduce the cardiac morbidity and mortality.  


Sign in / Sign up

Export Citation Format

Share Document